Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
Middle-aged women with (overweight/)obesity who will begin or have begun GLP-1 medication use will be recruited to complete a 12-week diet intervention study. For 12-weeks, participants will continue to take their GLP-1 medication and may be provided with protein-rich foods to consume every day. Body composition, eating behavior, health, and well-being will be measured before and after the study.
Epistemonikos ID: ecba44f6e90b6b6c0fee48d5fd8c4204984376bb
First added on: Mar 19, 2026